This research is part of a larger, long-term effort to aid the development of radiological interventions based on in vivo multimodal imaging, mainly quantitative PET imaging, for cancer diagnosis and treatment. These image-guided interventional procedures include biopsy, minimally invasive drug delivery and tumor ablation. Currently, PET imaging using [18F]-fluorodeoxyglucose (FDG) for tumor-detection does not utilize its full clinical potential. Accordingly, our research project addresses the correlation between PET measured tracer transport rate parameters (for FDG in this project) and histopathologically evaluated cancer prognostic factors. These cancer prognostic factors include pathologic type and grade, proliferation rate, p53 expression, etc. They are more useful for patient categorization, more crucial for treatment decisions, and more important for early assessment of the outcome of interventional procedures because they provide cellular level information as well as the microenvironment of the cancer. Our initial objective is to establish the woodchuck model of Hepatocellular Carcinoma (HCC) for quantitative FDG-PET imaging. Through multimodal imaging, we will align images from PET, CT and histology. Using functional analysis, we will correlate FDG transport parameters with cancer prognostic factors. We have assembled a strong research team with the needed expertise to accomplish our goal this BRG project. We hope that such correlation, if established, will lead to more successful cancer prognosis and early prediction of treatment efficacy and will thus have a huge impact on patient management. The methodology developed in this research can be applied to other tracers and used for other problem-specific research.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
1R01CA095307-01A1
Application #
6681264
Study Section
Diagnostic Imaging Study Section (DMG)
Program Officer
Menkens, Anne E
Project Start
2003-07-01
Project End
2007-06-30
Budget Start
2003-07-01
Budget End
2004-06-30
Support Year
1
Fiscal Year
2003
Total Cost
$368,389
Indirect Cost
Name
Case Western Reserve University
Department
Radiation-Diagnostic/Oncology
Type
Schools of Medicine
DUNS #
077758407
City
Cleveland
State
OH
Country
United States
Zip Code
44106
Lee, Zhenghong (2016) [18F]-choline PET/CT as an imaging biomarker for primary liver cancers. Transl Cancer Res 5:S1489-S1492
Lee, Zhenghong; Luo, Guangbin (2014) Issues pertaining to PET imaging of liver cancer. J Fasting Health 2:62-64
Kuang, Yu; Wang, Fangjing; Corn, David J et al. (2014) Metabolism of radiolabeled methionine in hepatocellular carcinoma. Mol Imaging Biol 16:44-52
Kuang, Yu; Wang, Fangjing; Corn, David J et al. (2014) In vitro characterization of uptake mechanism of L-[methyl-(3)H]-methionine in hepatocellular carcinoma. Mol Imaging Biol 16:459-68
Tenley, Nathan; Corn, David J; Yuan, Lewis et al. (2013) The effect of fasting on PET Imaging of Hepatocellular Carcinoma. J Cancer Ther 4:561-567
Kuang, Yu; Salem, Nicolas; Tian, Haibin et al. (2011) Imaging lipid synthesis in hepatocellular carcinoma with [methyl-11c]choline: correlation with in vivo metabolic studies. J Nucl Med 52:98-106
Kolthammer, Jeffrey A; Corn, David J; Tenley, Nathan et al. (2011) PET imaging of hepatocellular carcinoma with 18F-fluoroethylcholine and 11C-choline. Eur J Nucl Med Mol Imaging 38:1248-56
Salem, Nicolas; Kuang, Yu; Corn, David et al. (2011) [(Methyl)1-(11)c]-acetate metabolism in hepatocellular carcinoma. Mol Imaging Biol 13:140-51
Lu, Xincheng; Guo, Hong; Molter, Joseph et al. (2011) Alpha-fetoprotein-thymidine kinase-luciferase knockin mice: a novel model for dual modality longitudinal imaging of tumorigenesis in liver. J Hepatol 55:96-102
Kuang, Yu; Salem, Nicolas; Corn, David J et al. (2010) Transport and metabolism of radiolabeled choline in hepatocellular carcinoma. Mol Pharm 7:2077-92

Showing the most recent 10 out of 18 publications